IsoRay Inc. (ISR) is a Medical Specialities company listed on AMEX. There were no new wire items for ISR in the last 30 days. The most recent was published Feb 5, 2024.
Latest news
25 items- SECIsoRay Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
- INSIDERWilliamson Robert F Iii bought $90,710 worth of shares (127,206 units at $0.71), increasing direct ownership by 60% to 338,761 units (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERWilliamson Robert F Iii bought $78,474 worth of shares (135,879 units at $0.58), increasing direct ownership by 180% to 211,555 units (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERPuhlmann Markus bought $139,888 worth of shares (280,000 units at $0.50), increasing direct ownership by 26% to 1,375,425 units (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERWilliamson Robert F Iii bought $25,478 worth of shares (51,996 units at $0.49), increasing direct ownership by 220% to 75,676 units (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- SECSEC Form D filed by IsoRay Inc.D - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECIsoRay Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECSEC Form 424B5 filed by IsoRay Inc.424B5 - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECIsoRay Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECSEC Form 424B5 filed by IsoRay Inc.424B5 - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECIsoRay Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)8-K/A - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECIsoRay Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECIsoRay Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECIsoRay Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECIsoRay Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
- SECIsoRay Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
- INSIDERWilliamson Robert F Iii bought $1,203 worth of shares (3,663 units at $0.33) (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERHunt Jonathan Robert bought $32,338 worth of shares (125,000 units at $0.26), increasing direct ownership by 65% to 316,710 units (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERWilliamson Robert F Iii bought $6,978 worth of shares (23,680 units at $0.29) (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERPuhlmann Markus bought $188,737 worth of shares (595,425 units at $0.32), increasing direct ownership by 119% to 1,095,425 units (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERWoods Lori A bought $49,989 worth of shares (185,200 units at $0.27) (SEC Form 4)4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- SECSEC Form EFFECT filed by IsoRay Inc.EFFECT - Perspective Therapeutics, Inc. (0000728387) (Filer)
- INSIDERSEC Form 4 filed by Puhlmann Markus4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERSEC Form 4 filed by Spoor Johan M.4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
- INSIDERSEC Form 4 filed by Hunt Jonathan Robert4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
ISR FAQ
7 questionsWhat does IsoRay Inc. do?
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are...What is the latest news on ISR?
Quantisnow has not tracked any new filings, ratings or press releases for ISR in the last 30 days. The most recent wire item was published on February 5, 2024.Where does ISR stock trade?
IsoRay Inc. (ISR) is listed on AMEX.What sector and industry is ISR in?
IsoRay Inc. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about ISR?
IsoRay Inc. has had 1 recent analyst action on file. The most recent action was from Northland Capital Markets: Outperform with a $1.25 price target on 2021-09-14. Recent price targets cluster around $1.25.What companies are similar to ISR?
Notable peers in the same industry include ELV (Elevance Health Inc.), HUM (Humana Inc.), NTRA (Natera Inc.), CI (The Cigna Group), UNH (UnitedHealth Group Incorporated). Compare ISR side-by-side with any of them on Quantisnow.How can I track ISR on Quantisnow?
Quantisnow aggregates IsoRay Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ISR to receive live email and push alerts on every new disclosure.